Samuel Hall is no longer serving in their board position at Stoke Therapeutics, Inc.

Jun 05, 2020
Board and Executive Moves
Background Information
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.